Skip to main content
. 2021 Sep 21;27(35):5851–5889. doi: 10.3748/wjg.v27.i35.5851

Table 4.

Phase of trial and level of evidence of trial about chemotherapy for resectable and borderline resectable pancreatic ductal adenocarcinoma

Ref.
Phase of trial
Level of evidence
Neoptolemos et al[185] III II
Oettle et al[186] III I
Neoptolemos et al[187] III I
Neoptolemos et al[188] III I
Conroy et al[189] III I
You et al[195] III II
van Roessel et al[198] IV II
Versteijne et al[202] III II
Ghaneh et al[205] II II
Sohal et al[207] IV II
Labori et al[209] III II
Schwarz et al[210] II I
Ettrich et al[211] II II
Motoi et al[212] III II
UMIN-CTR Clinical Trial[215] (UMIN000026858) III II